Bemis confirms talks to buy Alcan Packaging
Bemis has confirmed that “confidential efforts are ongoing” in its attempt to acquire Alcan Packaging, which has been up for sale since mining giant Rio Tinto bought its parent company.
Archives for May 3, 2009
First USP OK for rHAs a "significant advantage", says Novozymes
Two recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph.
Greece bans flu drug exports
Greek authorities have banned the export of the anti-virals Relenza and Tamiflu to prevent the country’s stockpile being sold off through parallel trade as global demand for the drugs increases on concerns about a H1N1 influenza pandemic.
Appointments at Cardiocore and HUNT Biosciences – People on the move
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at Cardiocore and HUNT Biosciences.
Budenheim OKed to make phosphates for pharma
German industrial phosphate maker Budenheim has been certified to produce calcium phosphates as pharmaceutical excipients under ICH Q7A GMP guidelines.
San Diego plant will help clients concentrate on R&D, says Althea
Althea Technologies’ biologics and injectables contract development, manufacturing and testing facility in San Diego, US is open for business, bringing to an end the firm’s two year campaign to expand capacity.
SEC investigating insider trading in Merck - Schering deal
Suspicious spikes in the trading of Schering-Plough shares prior to its merger with Merck & Co are being investigating by the SEC, according to media reports.